Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2015 3
2016 2
2017 3
2018 4
2019 3
2020 5
2021 6
2022 1
2024 3
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Targeted Therapies in HER2-Overexpressing Metastatic Breast Cancer.
Labidi S, Mejri N, Lagha A, Daoud N, El Benna H, Afrit M, Boussen H. Labidi S, et al. Among authors: el benna h. Breast Care (Basel). 2016 Dec;11(6):418-422. doi: 10.1159/000452194. Epub 2016 Nov 15. Breast Care (Basel). 2016. PMID: 28228709 Free PMC article. Review.
Genetic testing for hereditary cancer syndromes in Tunisian patients: Impact on health system.
Jandoubi N, Boujemaa M, Mighri N, Mejri N, Ben Nasr S, Bouaziz H, Berrazega Y, Rachdi H, Daoud N, Zribi A, Ayari J, El Benna H, Labidi S, Haddaoui A, Mrad R, Ben Ahmed S, Boussen H, Abdelhak S, Boubaker S, Hamdi Y. Jandoubi N, et al. Among authors: el benna h. Transl Oncol. 2024 May;43:101912. doi: 10.1016/j.tranon.2024.101912. Epub 2024 Feb 21. Transl Oncol. 2024. PMID: 38387387 Free PMC article.
Association between epidemiological and clinico-pathological features of breast cancer with prognosis, family history, Ki-67 proliferation index and survival in Tunisian breast cancer patients.
Mighri N, Mejri N, Boujemaa M, Berrazega Y, Rachdi H, El Benna H, Labidi S, Benna F, Boubaker S, Boussen H, Abdelhak S, Hamdi Y. Mighri N, et al. Among authors: el benna h. PLoS One. 2022 Sep 12;17(9):e0269732. doi: 10.1371/journal.pone.0269732. eCollection 2022. PLoS One. 2022. PMID: 36094928 Free PMC article.
Uncovering the clinical relevance of unclassified variants in DNA repair genes: a focus on BRCA negative Tunisian cancer families.
Boujemaa M, Nouira F, Jandoubi N, Mejri N, Bouaziz H, Charfeddine C, Ben Nasr S, Labidi S, El Benna H, Berrazega Y, Rachdi H, Daoud N, Benna F, Haddaoui A, Abdelhak S, Samir Boubaker M, Boussen H, Hamdi Y. Boujemaa M, et al. Among authors: el benna h. Front Genet. 2024 Jan 19;15:1327894. doi: 10.3389/fgene.2024.1327894. eCollection 2024. Front Genet. 2024. PMID: 38313678 Free PMC article.
Germline copy number variations in BRCA1/2 negative families: Role in the molecular etiology of hereditary breast cancer in Tunisia.
Boujemaa M, Hamdi Y, Mejri N, Romdhane L, Ghedira K, Bouaziz H, El Benna H, Labidi S, Dallali H, Jaidane O, Ben Nasr S, Haddaoui A, Rahal K, Abdelhak S, Boussen H, Boubaker MS. Boujemaa M, et al. Among authors: el benna h. PLoS One. 2021 Jan 27;16(1):e0245362. doi: 10.1371/journal.pone.0245362. eCollection 2021. PLoS One. 2021. PMID: 33503040 Free PMC article.
30 results